Bohoněk M.1, Petráš M.1, Turek I.1, Urbanová J.1, Hrádek T.1, Staropražská V.1, Koštířová J.1, Horčičková D.1, Duchková S.1, Svobodová J.2, Tejčková E.2:
Quality parameters of cryopreserved red cells
reconstituted in AS-3 solution (Nutricel)
|
208 |
Bohoněk M.1, Horčičková D.1, Blažková M.1, Lejdar T.2, Švenda P.:
Computer crossmatch - performance,
validation and first implementation in the Czech Republic
|
217 |
Koza V.1,2, Cetkovský P.3, Faber E.4, Hájek R.5, Indrák K.4, Ivašková E.6, Jebavý L.7, Jindra P.1,2, Kozák T.8, Mayer J.5, Sedláček P.9, Starý J.9, Trněný M.10, Vítek A.3, Vorlíček J.5, Žák P.7:
Indications
of allogeneic and autologous haematopoietic cells transplantations. Recommendations of the Czech Socienty of Haematology
and Czech Society of Oncology of the J. E. Purkyně Czech Medical Association
|
223 |
Cmunt E.1, Trněný M.1, Karban J.1, Šálková J.1, Michalová K.2, Zemanová Z.2, Pavlištová L.2,Schwarz J.3, Peková S.3:
The risk factors analysis in 248 patients with B-cell chronic lymphocytic leukemia at
diagnosis
|
232 |
Vokurka S., Koza V., Jindra P., Steinerová K., Vozobulová V., Schűtzová M., Lysák D., Švojgrová M., Mohammad L., Karas M., Svoboda T.:
Significance of immunotherapy with anti-CD20 rituximab
and high-dose chemotherapy with autologous peripheral blood stem-cell transplantation in first-line treatment
for mantle-cell lymphoma – centre experience
|
240 |
Zahradová L.1,2, Očadlíková D.1, Kovářová L.1,3, Hájek R.1,2, Buliková A.3, Penka M.3, Michálek J.1,4:
Evaluation
of antigen-specific lymphocytes anti-tumour effect with use of non-radioactive cytotoxicity test
|
244 |
Papajík T., Urbanová R., Procházka V., Indrák K.:
B-cell chronic lymphocytic leukemia
Part III: Current conventional options of first-line treatment
|
249 |
